東方生物(688298.SH):擬投資6億元實施東方基因生物芯片產研基地項目
格隆匯12月29日丨東方生物(688298.SH)公佈,基於公司戰略規劃及經營發展需要,做大做強主業,發展戰略技術平台,豐富體外診斷試劑品種,進一步提升產能配套能力,公司擬與成都市温江區人民政府(以下簡稱“甲方”)簽署《東方基因生物芯片產研基地項目投資協議》(以下簡稱“投資協議”),在成都市温江區投資設立公司下屬全資子公司,實施本項目,投資事項及投資協議主要就投資建設相關內容進行約定,投資總額約人民幣6億元。
項目名稱:東方基因生物芯片產研基地項目;建設內容:生物芯片產研基地。研發、生產品種包括:生物芯片(含量子點微流控生物芯片、量子點微流控分析儀)、基於熒光定量、時間分辨的體外診斷試劑等產品系列,主要應用於新冠病毒檢測、毒品檢測、傳染病檢測、腫瘤標誌物檢測等領域,與公司現有主營業務具有協同和補充效應。
投資金額:本項目投資總額人民幣6億元,其中項目公司註冊資本1億元,固定資產投資額不低於3.2億元(包括建築物、附着物、裝修及設備等),土地價格預估3200萬元左右。
本項目投資符合公司戰略規劃及經營發展需要,有利於公司做大做強主業,發展戰略技術平台,豐富體外診斷試劑品種,進一步提升產能配套能力,完善區域和市場佈局,具有持續深遠意義。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.